16 Dec 2020 12:18
LEI: 213800WRAP6W8VDL6B38
InnovaDerma PLC
("InnovaDerma" or the "Group")
Results of the Annual and General Meetings and Directorate Change
InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life science products, is pleased to announce that at its Annual General Meeting ("AGM") and General Meeting ("GM") held earlier today, all resolutions, were duly passed.
AGM Resolutions
Resolutions 9 and 10 were proposed as special resolutions. All other resolutions were proposed as ordinary resolutions. The proxy voting results for each resolution are as follows:
RESOLUTIONS | Votes For | % | Votes Against | % | Votes Cast | Vote withheld |
1. To receive and adopt the annual accounts for the year ended 30 June 2020. | 3,992,377 | 100.00 | 0 | 0.00 | 3,992,377 | 0 |
2. To receive and approve the director's remuneration report for the year ended 30 June 2020. | 3,961,740 | 99.76 | 9,674 | 0.24 | 3,971,414 | 20,963 |
3. To approve the Directors' Remuneration Policy | 3,940,740 | 99.48 | 20,674 | 0.52 | 3,961,414 | 30,963 |
4. To reappoint Elderton Audit UK as auditors of the company. | 3,981,377 | 99.72 | 11,000 | 0.28 | 3,992,377 | 0 |
5. To authorise the directors to fix the remuneration of the auditors. | 3,971,564 | 100.00 | 0 | 0.00 | 3,971,564 | 20,813 |
6. To reappoint Ross Andrews as a director. | 3,969,756 | 99.48 | 20,674 | 0.52 | 3,990,430 | 1,947 |
7. To reappoint Mark Michael Ward as a director. | 3,928,433 | 98.45 | 61,977 | 1.55 | 3,990,430 | 1,947 |
8. To confer on the Directors authority to allot securities in accordance with Section 551 of the Companies Act 2006. | 3,959,943 | 99.76 | 9,674 | 0.24 | 3,969,617 | 22,760 |
9. To confer on the Directors power to allot securities under a disapplication of Section 561 of the Companies Act 2006. | 3,949,943 | 99.50 | 19,674 | 0.50 | 3,969,617 | 22,760 |
10. To authorise the Company to make market purchases of its own shares for the purposes of Sections 693 and 701 of the Companies Act 2006. | 3,959,617 | 99.70 | 11,947 | 0.30 | 3,971,564 | 20,813 |
GM resolutions
RESOLUTIONS | Votes For | % | Votes Against | % | Vote Cast | Votes Withheld |
1. To appoint Simon Pyper as a director. | 3,889,595 | 94.78 | 214,097 | 5.22 | 4,103,692 | 10,900 |
2. To re-elect Joseph Bayer as a director. | 3,984,199 | 96.83 | 130,393 | 3.17 | 4,114,592 | 0 |
Directorate Change
As previously announced, Rodney Turner who has been a Non-executive Director of the Group since September 2014 has chosen not to stand for re-election and has stepped down from the Board from at the beginning of the General Meeting.
Following the passing of the resolution at the GM, the Group is pleased to announce the appointment of Simon Pyper a Non-Executive Director of the Group with immediate effect. Simon, will join the Nominations and Remuneration Committees and chair the Audit Committee thereby replacing Rodney's membership role in those committees. Simon was formerly the Chief Executive Officer and Chief Financial Officer of digital marketing group Be Heard Group plc. Simon was appointed Chief Financial Officer of Be Heard Group plc in May 2018 and undertook the role of CEO from September 2018. Prior to this, he was Chief Financial Officer of AIM listed GlobalData plc from 2007 to 2017. During his tenure, Simon oversaw its reverse takeover of TMN plc and admission to AIM and facilitated its acquisition led growth strategy. Simon is currently the Chief Financial Officer of Xenia Broking, one of the largest credit insurance brokers in the UK. He is a British citizen and resident of the UK.
The full text of all the resolutions can be found in the Notice of AGM and GM contained in the Group's Annual Report and Accounts which is available for viewing on the FCA's National Storage Mechanism at data.fca.org.uk/#/nsm/nationalstoragemechanism as well as from the Group's website at: https://www.innovaderma.com/company-publications
This announcement contains inside for the purposes of Article 7 of EU Regulation 596/2014.
Further enquiries
InnovaDerma Joe Bayer Blake Hughes
|
+61 417 870 743 c/o TB Cardew
|
finnCap Ltd Geoff Nash/Kate Bannatyne Alice Lane - Corporate Broking |
+44 (0)207 220 0500 www.finncap.com |
TB Cardew Shan Shan Willenbrock/ Olivia Rosser |
+ 44 (0)7775 848537 + 44 (0)20 7930 0777 innovaDerma@tbcardew.com
|